We provide four recommendations to improve the clarity and transparency of GiveWell’s cost-effectiveness analyses. These are to (1) publicly explain and defend their assumptions about the effect of deworming over time; (2) explain their cost-effectiveness analyses in writing; (3) illustrate the sensitivity of their results to key parameters; (4) make it clear when an estimate is subjective or evidence-based.
Joel McGuire
We update our previous analysis to incorporate the household spillover effects for cash transfers and psychotherapy. We estimate that psychotherapy is 9 times (95% CI: 2, 100) more cost-effective than cash transfers. The charity StrongMinds is estimated to be 9 times (95% CI: 1, 90) more cost-effective than the charity GiveDirectly.
Drawing on evidence from over 80 studies and over 140,000 participants, we compare the cost-effectiveness of cash transfers and psychotherapy by estimating their effect on the recipient's subjective wellbeing and affective mental health.
This report explains how we determined the cost-effectiveness of cash transfers using subjective wellbeing and affective mental health.
This report explains how we determined the cost-effectiveness of group or task-shifted psychotherapy in low- and middle-income countries using subjective wellbeing and affective mental health.
This report explains how we determined the cost-effectiveness of StrongMinds using subjective wellbeing and affective mental health.
We know that cash transfers reduce poverty, improve health and enhance education but what impact do they have on how people feel and think about their lives? We find that cash transfers have a small, positive effect on subjective wellbeing, one that lasts for several years.
We show how Wellbeing-Adjusted Life Years (WELLBYs) can be used to estimate the value of different outcomes. We then estimate the values of two key inputs in GiveWell’s analysis: doubling consumption for one person for one year and averting the death of a child under 5 years old.